Assyro AI

Orange Book product · Brand (NDA)

IVRA

MELPHALAN HYDROCHLORIDE

Brand (NDA)NDA 217110RX APOTEX

At a glance

Aug 18, 2023

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 18, 2023

    2 yr 11 mo ago

  2. Today

  3. Patent 10537520 expires

    Listed drug product patent expiration.

    Jun 29, 2036

    in 10 yr 2 mo

Pharmaceutical detail

Active ingredient

MELPHALAN HYDROCHLORIDE

Strength

EQ 90MG BASE/ML (EQ 90MG BASE/ML)

Dosage form

SOLUTION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 217110

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
10537520Jun 29, 2036in 10 yr 2 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.